辐射纤维化的临床表现和分子病原性
Mackenzie Fijardo1, Jennifer Yin Yee Kwan2, Pierre-Antoine Bissey3
1Research Institute, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario, Canada.
放射治疗的进步减少了毒性,但辐射诱导的纤维化仍然是一个挑战. 了解其原因和探索新的治疗方法对于改善癌症患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 纤维化研究 纤维化研究
背景情况:
- 现代放射治疗允许精确,高剂量瘤向,减少急性毒性.
- 辐射诱导纤维化是放射治疗的常见,渐进的长期副作用.
- 这种情况涉及异常的伤口愈合和过度的痕组织沉积,损害器官功能.
研究的目的:
- 审查放射治疗剂量计的原则,以尽量减少非目标效应.
- 描述辐射纤维化的临床和病理特征.
- 探索驱动辐射纤维化的细胞和分子机制,并讨论治疗策略.
主要方法:
- 文献综述整合了放射治疗原理,临床表现和分子病原性.
- 分析当前对辐射纤维化发展的理解.
- 检查预防和治疗的新兴治疗目标.
主要成果:
- 放射治疗技术的进步降低了整体毒性.
- 辐射纤维化是由异常的伤口修复引起的,导致组织硬化和功能障碍.
- 已经确定了驱动纤维化的关键细胞和分子通路.
结论:
- 尽量减少非目标辐射暴露是预防纤维化的关键.
- 对辐射纤维化病原体的更深入的理解对于有效的癌症治疗至关重要.
- 新兴疗法为预防和治疗辐射诱导纤维化提供了潜力.
更多相关视频
06:03Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
相关概念视频
Biological Effects of Radiation
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Mutations
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
